Julie M. Thibodeau

Biotonix (2010), Inc. engages in the research, development and commercialization of advanced software solutions and novel orthotics for healthcare and fitness professionals primarily in Canada, Japan, and the United States. Biotonix solutions enable health and fitness professionals to assess, improve and monitor posture and related back problems, overall fitness and bone health. Its applications are commercialized worldwide and also used by renowned North American universities as learning, research and diagnostic tools. It offers BioPrint, a system that assesses overall posture to correct and enhance postural health and related musculoskeletal disorders, back aches, and other posture-related pains. FitPrint which assesses posture and body alignment using fundamental biomechanics variables. AgePrint establish physiological age to enhance muscular balance, performance, and overall fitness, as well as to rejuvenate the body. The company also provides GolfPrint, a system that assesses static musculoskeletal position to identify a golfer's postural deviations, and connect their impact with various golfing factors, such as strength, shot precision, and consistency to generate a muscle-by-muscle customized corrective exercises program. It also offers customized health solutions for healthcare, fitness, and sports organizations. The company was founded by Sylvain Guimond in 1996 and is headquartered in Quebec, Canada.

Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada.